Subscribe
The team includes IP shareholders, two of whom will be based in New York
phototrip2403 / Shutterstock.com
17 July 2025NewsCareersSarah Speight

US firm Brownstein nabs five from Crowell ‘at pivotal moment’

Three of the new shareholders have IP and life sciences expertise, bringing a commercial and policy focus to the firm.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
11 July 2025   New hire is deeply involved in the litigation space and has co-founded two software businesses.
Careers
Kilpatrick adds ‘seasoned litigator’ as trademark partner
10 July 2025   The new partner brings more than 30 years’ experience, including in counselling pharmaceutical, life sciences, and medical device companies.
Europe
Lord Justice Birss to become chancellor of the High Court
2 July 2025   The prominent senior IP judge is known for his groundbreaking judgments on patents, AI and FRAND, such as Unwired Planet, Thaler's DABUS, and InterDigital.


Editor's picks

A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
Americas
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
23 October 2025

Editor's picks

Americas
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
23 October 2025
Americas
Top pharma, biotech, and medtech experts gather at LSPN Fall
21 October 2025
Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
16 October 2025
Americas
‘Death knell’ for investment: Universities warn against Lutnick’s royalty sharing proposal
13 October 2025
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
1 October 2025

More features

A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
Less is more: patent lawyers flip the script after Amgen
‘Doing more with less’: In-house counsel on budgets and strategy
End of the ‘Death Squad’? Squires puts PTAB on trial
Data and delivery: Inside AI's inventorship dilemma
Weil continues expansion with top trade secrets litigator
Top pharma, biotech, and medtech experts gather at LSPN Fall
Mitsubishi Tanabe doubles down on Radicava protection